OtherArticle
PHARMACOKINETICS AND METABOLISM OF THE PRODRUG DB289 IN RAT AND MONKEY AND ITS CONVERSION TO THE ANTIPROTOZOAL/ANTIFUNGAL DRUG DB75
Ian Midgley, Karen Fitzpatrick, Lynne M Taylor, Tara L Houchen, Simon J Henderson, Sarah J Wright, Zbigniew R Cybulski, Brian A John, Alan McBurney, David W Boykin and Kerri L Trendler
Drug Metabolism and Disposition March 14, 2007, DOI: https://doi.org/10.1124/dmd.106.013391
Ian Midgley
Karen Fitzpatrick
Lynne M Taylor
Tara L Houchen
Simon J Henderson
Sarah J Wright
Zbigniew R Cybulski
Brian A John
Alan McBurney
David W Boykin
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
PHARMACOKINETICS AND METABOLISM OF THE PRODRUG DB289 IN RAT AND MONKEY AND ITS CONVERSION TO THE ANTIPROTOZOAL/ANTIFUNGAL DRUG DB75
Ian Midgley, Karen Fitzpatrick, Lynne M Taylor, Tara L Houchen, Simon J Henderson, Sarah J Wright, Zbigniew R Cybulski, Brian A John, Alan McBurney, David W Boykin and Kerri L Trendler
Drug Metabolism and Disposition March 14, 2007, DOI: https://doi.org/10.1124/dmd.106.013391
OtherArticle
PHARMACOKINETICS AND METABOLISM OF THE PRODRUG DB289 IN RAT AND MONKEY AND ITS CONVERSION TO THE ANTIPROTOZOAL/ANTIFUNGAL DRUG DB75
Ian Midgley, Karen Fitzpatrick, Lynne M Taylor, Tara L Houchen, Simon J Henderson, Sarah J Wright, Zbigniew R Cybulski, Brian A John, Alan McBurney, David W Boykin and Kerri L Trendler
Drug Metabolism and Disposition March 14, 2007, DOI: https://doi.org/10.1124/dmd.106.013391
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement